UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells

Journal of Biological Chemistry

Volumn 282, Issue 46, 2007, Pages 33466-33474

  Chouinard, Sarah ^a,b   Barbier, Olivier ^a,b   Bélanger, Alain ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGENS; CELL HOMOGENATES; PROTEIN LEVELS;

CELLS; DATA REDUCTION; GENES; METABOLITES; RNA; TUMORS;

ENZYME KINETICS;

ANDROSTANEDIOL; ANDROSTANOLONE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 2B15; GLUCURONOSYLTRANSFERASE 2B17; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONJUGATION; CONTROLLED STUDY; ENZYME INHIBITION; GLUCURONIDATION; HORMONE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANDROGENS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 36348992078     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M703370200     Document Type: Article

References (56)

1. Zhou, Z. X., Lane, M. V., Kemppainen, J. A., French, F. S., and Wilson, E. M. (1995) Mol. Endocrinol. 9, 208-218
2. Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., and Chouinard, S. (2003) Trends Endocrinol. Metab. 14, 473-479
3. Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S. X., and Pelletier, G. (2003) Endocr. Rev. 24, 152-182
4. Geller, J., and Albert, J. (1987) Urol. Res. 15, 151-153
5. Bélanger, B., Bélanger, A., Labrie, F., Dupont, A., Cusan, L., and Monfette, G. (1989) J. Steroid Biochem. 32, 695-698
6. Page, S. T., Amory, J. K., Anawalt, B. D., Irwig, M. S., Brockenbrough, A. T., Matsumoto, A. M., and Bremner, W. J. (2006) J. Clin. Endocrinol. Metab. 91, 4374-4380
7. Labrie, F. (1991) Mol. Cell. Endocrinol. 78, 113-118
8. Couture, J. F., de Jesus-Tran, K. P., Roy, A. M., Cantin, L., Cote, P. L., Legrand, P., Luu-The, V., Labrie, F., and Breton, R. (2005) Protein Sci. 14, 1485-1497
9. Liu, H., Robert, A., and Luu-The, V. (2005) J. Steroid Biochem. Mol. Biol. 94, 173-179
10. Green, M. D., Oturu, E. M., and Tephly, T. R. (1994) Drug Metab. Dispos. 22, 799-805
11. Lévesque, É., Beaulieu, M., Green, M. D., Tephly, T. R., Bélanger, A., and Hum, D. W. (1997) Pharmacogenetics 7, 317-325
12. Turgeon, D., Carrier, J.-S., Lévesque, E., Hum, D. W., and Bélanger, A. (2001) Endocrinology 142, 778-787
13. Beaulieu, M., Lévesque, E., Hum, D. W., and Bélanger, A. (1996) J. Biol. Chem. 271, 22855-22862
14. Evans, W. E., and Relling, M. V. (1999) Science 286, 487-491
15. Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro, S. I., Iyanagi, T., Miners, J. O., Owens, I. S., and Nebert, D. W. (2005) Pharmacogenet. Genomics 15, 677-685
16. Dutton, G. J. (1980) Glucuronidation of Drugs and Other Compounds, CRC Press, Boca Raton, FL
17. Chouinard, S., Pelletier, G., Bélanger, A., and Barbier, O. (2006) Endocrinology 147, 5431-5442
18. Vandenput, L., Labrie, F., Mellstrom, D., Swanson, C., Knutsson, T., Peeker, R., Ljunggren, O., Orwoll, E., Eriksson, A. L., Damber, J. E., and Ohlsson, C. (2007) J. Bone Miner. Res. 22, 220-227
19. Barbier, O., Lapointe, H., El Alfy, M., Hum, D. W., and Bélanger, A. (2000) J. Clin. Endocrinol. Metab. 85, 4819-4826
20. Chouinard, S., Pelletier, G., Bélanger, A., and Barbier, O. (2004) Endocr. Res. 30, 717-725
21. MacLeod, S. L., Nowell, S., Plaxco, J., and Lang, N. P. (2000) Ann. Surg. Oncol. 7, 777-782
22. Park, J., Chen, L., Shade, K., Lazarus, P., Seigne, J., Patterson, S., Helal, M., and Pow-Sang, J. (2004) J. Urol. 171, 2484-2488
23. Hajdinjak, T., and Zagradisnik, B. (2004) Prostate 59, 436-439
24. Okugi, H., Nakazato, H., Matsui, H., Ohtake, N., Nakata, S., and Suzuki, K. (2006) Cancer Detect. Prev. 30, 262-268
25. Turgeon, D., Chouinard, S., Bélanger, P., Picard, S., Labbe, J. F., Borgeat, P., and Bélanger, A. (2003) J. Lipid Res. 44, 1182-1191
26. Guillemette, C., Hum, D. W., and Bélanger, A. (1996) Endocrinology 137, 2872-2879
27. Guillemette, C., Lévesque, E., Beaulieu, M., Turgeon, D., Hum, D. W., and Bélanger, A. (1997) Endocrinology 138, 2998-3005
28. Lévesque, E., Beaulieu, M., Guillemette, C., Hum, D. W., and Bélanger, A. (1998) Endocrinology 139, 2375-2381
29. Labrie, F., Bélanger, A., Bélanger, P., Berube, R., Martel, C., Cusan, L., Gomez, J., Candas, B., Chaussade, V., Castiel, I., Deloche, C., and Leclaire, J. (2007) J. Steroid Biochem. Mol. Biol. 103, 178-188
30. Guillemette, C., and Bélanger, A. (1995) Mol. Cell. Endocrinol. 107, 131-139
31. Ma, A. H., Xia, L., Desai, S. J., Boucher, D. L., Guan, Y., Shih, H. M., Shi, X. B., Devere White, R. W., Chen, H. W., Tepper, C. G., and Kung, H. J. (2006) Cancer Res. 66, 8439-8447
32. Kazmin, D., Prytkova, T., Cook, C. E., Wolfinger, R., Chu, T. M., Beratan, D., Norris, J. D., Chang, C. Y., and McDonnell, D. P. (2006) Mol. Endocrinol. 20, 1201-1217
33. Prescott, J., Jariwala, U., Jia, L., Cogan, J. P., Barski, A., Pregizer, S., Shen, H. C., Arasheben, A., Neilson, J. J., Frenkel, B., and Coetzee, G. A. (2007) Prostate 67, 1371-1383
34. Arnold, J. T., Le, H., McFann, K. K., and Blackman, M. R. (2005) Am. J. Physiol. Endocrinol. Metab. 288, 573-584
35. Xu, L. L., Srikantan, V., Sesterhenn, I. A., Augustus, M., Dean, R., Moul, J. W., Carter, K. C., and Srivastava, S. (2000) J. Urol. 163, 972-979
36. Korkmaz, K. S., Korkmaz, C. G., Ragnhildstveit, E., Kizildag, S., Pretlow, T. G., and Saatcioglu, F. (2000) Gene (Amst.) 260, 25-36
37. Jacquinet, E., Rao, N. V., Rao, G. V., Zhengming, W., Albertine, K. H., and Hoidal, J. R. (2001) Eur. J. Biochem. 268, 2687-2699
38. Lin, B., Ferguson, C., White, J. T., Wang, S., Vessella, R., True, L. D., Hood, L., and Nelson, P. S. (1999) Cancer Res. 59, 4180-4184
39. Jia, L., Shen, H. C., Wantroba, M., Khalid, O., Liang, G., Wang, Q., Gentzschein, E., Pinski, J. K., Stanczyk, F. Z., Jones, P. A., and Coetzee, G. A. (2006) Mol. Cell. Biol. 26, 7331-7341
40. Korkmaz, K. S., Korkmaz, C. G., Pretlow, T. G., and Saatcioglu, F. (2001) DNA Cell Biol. 20, 435-445
41. Dong, Y., Bui, L. T., Odorico, D. M., Tan, O. L., Myers, S. A., Samaratunga, H., Gardiner, R. A., and Clements, J. A. (2005) Endocr. Relat. Cancer 12, 875-889
42. Mabjeesh, N. J., Willard, M. T., Frederickson, C. E., Zhong, H., and Simons, J. W. (2003) Clin. Cancer Res. 9, 2416-2425
43. Chen, S., Yong, W., Hong-Hong, Y., Yun-Tao, Z., Chang-Hong, S., Fan, L., Ting-Yi, B., Zeng-Yue, Y., Jian-Lin, Y., and Guo-Xing, S. (2007) J. Androl., in press
44. Sonnenschein, C., Olea, N., Pasanen, M. E., and Soto, A. M. (1989) Cancer Res. 49, 3474-3481
45. Berns, E. M., de Boer, W., and Mulder, E. (1986) Prostate 9, 247-259
46. He, W. W., Sciavolino, P. J., Wing, J., Augustus, M., Hudson, P., Meissner, P. S., Curtis, R. T., Shell, B. K., Bostwick, D. G., Tindall, D. J., Gelmann, E. P., Abate-Shen, C., and Carter, K. C. (1997) Genomics 43, 69-77
47. Kanaya, J., Takashima, M., Koh, E., and Namiki, M. (2003) Asian J. Androl. 5, 9-13
48. Beaulieu, M., Lévesque, É., Hum, D. W., and Bélanger, A. (1998) Biochem. Biophys. Res. Commun. 248, 44-50
49. Kim, J., and Coetzee, G. A. (2004) J. Cell. Biochem. 93, 233-241
50. Balk, S. P., Ko, Y. J., and Bubley, G. J. (2003) J. Clin. Oncol. 21, 383-391
51. Cheng, H., Snoek, R., Ghaidi, F., Cox, M. E., and Rennie, P. S. (2006) Cancer Res. 66, 10613-10620
52. Bélanger, A., Couture, J., Caron, S., and Roy, R. (1990) Ann. N. Y. Acad. Sci. 595, 251-259
53. Farnsworth, W. E., and Brown, J. R. (1976) Endocr. Res. Commun. 3, 105-117
54. Hammond, G. L. (1978) J. Endocrinol. 78, 7-19
55. Rittmaster, R. S., Zwicker, H., Thompson, D. L., Konok, G., and Norman, R. W. (1993) J. Clin. Endocrinol. Metab. 76, 977-982
56. El-Alfy, M., Luu-The, V., Huang, X. F., Berger, L., Labrie, F., and Pelletier, G. (1999) Endocrinology 140, 1481-1491